Anat Hakim
Secretary, Executive VP & General Counsel
|
Andy Vicari
Senior Director & US Brand Leader-Insulins
|
Anne E. White
Executive Vice President-Lilly Neuroscience
|
Christian Nguyen
VP-Global Patient Outcomes & Real World Evidence
|
Daniel M. Skovronsky
Chief Scientific Officer & Executive VP
|
David A. Ricks
Chairman, President & Chief Executive Officer
|
David Hyman
Chief Medical Officer
|
Diogo Rau
Executive VP, Chief Information & Digital Officer
|
Donald A. Zakrowski
Chief Accounting Officer & Vice President-Finance
|
Edgardo Hernandez
President-Manufacturing Operations & Senior VP
|
Eric Dozier
Executive VP-Human Resources & Diversity
|
Gabrielle G. Greene-Sulzberger
Independent Director
|
Ilya Yuffa
Senior VP & President-Lilly Bio Medicines
|
Jacob S. van Naarden
Executive Vice President
|
Jamere Jackson
Independent Director
|
Jennifer Oleksiw
Global Chief Customer Officer & Vice President
|
Joe Fletcher
Investor Relations Contact
|
Jon Erik Fyrwald
Independent Director
|
Jon R. Moeller
Director
|
Juan Ricardo Luciano
Lead Independent Director
|
Katherine Baicker
Independent Director
|
Kim Macko
Head-Global Brand Development
|
Kimberly H. Johnson
Independent Director
|
Laura A. Lane
Vice President
|
Lucas E. Montarce
Chief Financial Officer & Executive Vice President
|
Mark Genovese
Senior Vice President-Immunology Development
|
Mary Lynne Hedley
Independent Director
|
Melissa Seymour
Executive Vice President-Global Quality
|
Nathaniel R. Miles
Vice President-Strategic Initiatives
|
Patrik Jonsson
EVP, President-Lilly Diabetes & Obesity
|
Ralph Alvarez
Independent Director
|
Robert Conley
Development Leader-Neuroscience
|
Robert J. Heine
Vice President-Medical Affairs
|
Ruth Gimeno
Vice President
|
Thomas Fuchs
Chief Artificial Intelligence Officer
|
William G. Kaelin
Independent Director
|
